FDA Approves Lou Gehrig's Disease Drug From Cambridge-Based Drugmaker

WBZ NewsRadio 1030 - News Audio

English - September 30, 2022 23:39 - 49 seconds - 763 KB - ★★★★ - 18 ratings
News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Andover Man Jumps In Charles River After His Phone Fall In, Finds 10 More

Next Episode: Massachusetts Case Of Listeria Reported, Over 20 Cheese Brands Recalled

Some ALS advocates and patients pushed for the drug's release, but the FDA approved Relyvrio without a large-scale human trial. WBZ's Kim Tunnicliffe reports: